Treatments and Therapies Topics (required) InformationAdviceNewsReal storiesResearchSupport usDementia directory
Research Three promising drugs for treating Alzheimer's disease bring fresh hope For the first time, drugs that slow down memory and thinking decline in early Alzheimer’s disease have been approved by UK regulators. Here we explore the next wave of promising new drugs: remternetug, butanetap and semaglutide. For the first time, drugs that slow down memory and thinking decline in early Alzheimer’s disease have been approved by UK regulators. Here we explore the next wave of promising new drugs: remternetug, butanetap and semaglutide. ... 22 August 2024
Real stories Reminiscence therapy helped my mum with dementia return to her roots Alzheimer's Society volunteer Chantal Clairicia explains how, following her mum Armelle's dementia diagnosis, reminiscence therapy took her family on an emotional journey to explore their roots in Guadeloupe. Alzheimer's Society volunteer Chantal Clairicia explains how, following her mum Armelle's dementia diagnosis, reminiscence therapy took her family on an emotional journey to explore their roots in Guadeloupe. ... 24 October 2023
News Tag: News. Alzheimer's Society respond to FDA decision on Alzheimer's drug lecanemab The Food and Drug Administration has today approved lecanemab, a new drug for Alzheimer's disease, for use across the US. Read more
News Tag: News. Alzheimer's Society comment on disappointing results for gantenerumab drug at clinical trial Alzheimer's Society, study participant Eric Deeson and Sir Prof John Hardy comment on the disappointing clinical trial results for Alzheimer's drug gantenerumab. Read more
News Tag: News. Alzheimer's Society comment on today's 'breakthrough' Alzheimer's drug news Dr Richard Oakley, Associate Director of Research at Alzheimer’s Society, comments on news surrounding breakthrough Alzheimer's drug lecanemab. Read more
News Tag: News. Progress with new Alzheimer’s drug lecanemab announced by manufacturers Eisai and Biogen Yesterday (27 September 2022), Eisai Co. Ltd. and Biogen announced top-line results for a major trial on the drug lecanemab in slowing down the progress of Alzheimer’s disease. Alzheimer's Society comments on this Alzheimer’s progression drug hope. Read more
Research What is Aducanumab and what could this dementia drug mean for people with Alzheimer's disease? Aducanumab is a drug that has been developed as a potential treatment for Alzheimer’s disease. Find out more about the drug, its path to approval in the US, and what it means for people with dementia in the UK. Aducanumab is a drug that has been developed as a potential treatment for Alzheimer’s disease. Find out more about the drug, its path to approval in the US, and what it means for people with dementia in the UK. ... 22 December 2021
News Tag: News. Alzheimer's Society responds to EMA rejection of aducanumab The European Medicines Agency (EMA) has recommended that aducanumab, marketed as Aduhelm, is not approved for use across the EU. The drug was previously approved for use in the US by the Food and Drug Administration (FDA) on 7 June 2021. Read more
Real stories Art therapy helps my grandmother with her dementia and my autism James is a young artist with autism who helps to care for his grandmother, Joan. She moved in with James and his mum when the first coronavirus lockdown made Joan isolated and confused. Now Joan, who has vascular dementia, and James are regularly enjoying artistic activities together and both benefit from them. James is a young artist with autism who helps to care for his grandmother, Joan. She moved in with James and his mum when the first coronavirus lockdown made Joan isolated and confused. Now Joan, who has vascular dementia, and James are regularly enjoying artistic activities together and both benefit from them. ... 20 September 2021 3comments.
Info Page Tag: Info Page. Immune system retargeted to remove toxic protein From the Summer 2016 edition of Care and cure magazine, injections of an immune system protein can trigger the fight against the signs of Alzheimer's disease in mice. Read more
Info Page Tag: Info Page. Investigating how to clear toxic amyloid protein from the brain in Alzheimer’s disease Research project: Understanding the molecular basis of Amyloid beta peptide interaction by neprilysin in Alzheimer’s disease. Read more
Info Page Tag: Info Page. Understanding the effects of the diabetes type 2 drug Metformin on models of Alzheimer’s disease Research project: Metformin in Alzheimer’s disease Read more
Dementia Support Line